Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02925585 · ClinicalTrials.gov registry record
Vaginal Tactile Imaging for Pelvic Floor Prolapse
A clinical trial, sponsored by Artann Laboratories.
- Completed
- Registry status
- 119
- Enrollment target
NCT02925585: Completed study, sponsored by Artann Laboratories.
NCT02925585 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02925585 has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.
Primary Outcome
Tissue elasticity is measured for entire anterior and posterior compartments
Interventions
- OTHER Pre/post imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-12 |
What the finished NCT02925585 record still lists
NCT02925585 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pre/post imaging is the first listed.
NCT02925585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02925585 about?
NCT02925585 is a clinical study titled "Vaginal Tactile Imaging for Pelvic Floor Prolapse". The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.
What is the current status of trial NCT02925585?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2016-09. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02925585?
The interventions under investigation include: Pre/post imaging (OTHER).
Who is sponsoring clinical trial NCT02925585?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia